LOX and gastric cancer: Meanwhile, the results of LOGpc analyses indicated that the increased LOX, LOXL2-4 mRNA expression were associated with low OS (p < 0.05) in patients with GC, but the expression of LOXL1 had no correction with prognosis (p > 0.05) in patients with GC (Figure 4B).